Plain-English translation of NCT07211126 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →This study is looking at how well the t:slim X2 insulin pump with Control-IQ technology works when people with type 1 diabetes use it in their daily lives. The Control-IQ System is an automated insulin pump that works with a continuous glucose monitor (a small sensor that tracks blood sugar). Researchers want to understand whether the medication is safe, how well it controls blood sugar, and whether people feel satisfied and confident using it.
Even though this treatment has been approved by regulators, companies are required to keep watching how it performs when thousands of real patients use it at home—not just in controlled clinical trials. This study will help doctors and patients understand what to expect from the treatment in everyday life.
You likely qualify if…
You likely don't qualify if…
You would use your insulin pump system as you normally would at home, following your doctor's standard care instructions. Over 12 months, you would share your blood sugar readings and health information with the research team, and answer questionnaires about how satisfied you are with the device and how it affects your daily life. The study is designed to fit into your regular routine rather than requiring extra clinic visits.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France